PAULO CALDEIRA

Serviço de Gastrenterologia, Hospital Distrital de Faro, Faro Portugal.

 

Tratamento da Doença Ano-rectal

 

SA Hyder, SP Travis, DP Jewel, NM Mortensen e BD George.

Fistulating Anal Crohn's Disease: Results of Combined Surgical and InfliximabTreatment

Dis Colon Rectum, 2006; 49: 1837-41

 

Texto completo disponível apenas em PDF.

Full text only available in PDF format.

 

BIBLIOGRAFIA

1. Present DH, Rutgeerts O, Targan S, et al. Infliximab for treatment of fistulas in patients with Crohn's disease. N Eng J Med 1999; 340: 1398-405.

2. Sands BE, Anderson FH, Bernestein CN, et al. Infliximab maintenance for fistulizing Crohn's disease. N Eng J Med 2004M; 350: 876-85

3. Van Assche G, Vanbeckevoort D, Bielen, et al Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Am J Gastroenterol. 2003 Feb;98(2): 332-9.

4. Sands BE, Blank MA Diamond RH, Barret JP, van Deventer SJ. Maintenance infliximab does not result in increased abcess development in fistulizing Crohn's disease: results from ACCENT II study. Aliment Pharmacol Ther 2006; 23: 1127-36

5. Topstat DR, Pannacione R, Heine JA, Johnson DR, MacLean AR, Buie WD. Combined seton placement, infliximab infusion and maintenance immunossupressives improve healing rate in fistulizing anorectal Crohn´s disease: a single center experience, Dis Colon Rectum 2003; 46: 577-83

6. Regueiro M, Mardini H. Teatmente of perianal fistulizing Crohn´s disease wuith infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflam Bowel Dis 2003;9: 98-103

7. Talbot C, Sagar PM, Johson MJ, Finan PJ, Burke D. Infliximab in the surgical management of complex fistulating anal Crohn´s disease. Colorectal Dis 2005;7: 164-82005